Breast Cancer Imaging Market

Breast Cancer Imaging Market by Types of Imaging Techniques (Mammography, Breast Ultrasound, and Breast MRI, Image-guided Breast Biopsy, and Others), End-users (Hospitals, Diagnostic Centers, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1418
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global breast cancer imaging market size was valued USD 3.6 billion in 2020 and is anticipated to register at a robust CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the improved quality of breast images, patient comfort, and reduced patient dose.


Breast Cancer Imaging Market Key Takeaways

Breast cancer imaging system is a diagnostic tool utilized for locating the site of cancer cells. It provides detailed information such as extent of the disease as well as the structural changes. Cancer imaging systems detect the tumor in the body and its associated complications, which helps in the evaluation of the post therapeutic treatment by specialists.

Breast cancer imaging is also used to evaluate the stages. Mammography, ultrasonography, and breast magnetic resonance imaging (MRI) are three types of imaging systems that are used for detection of breast cancer.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing technological advancements in the field of breast imaging and rising investment from different organizations for breast cancer screening campaigns are projected to boost the market growth.
  • Patient is exposed to multiple sets of radiations for therapeutic purposes during breast imaging procedures, which can create challenges for the growth of the market.
  • Growing awareness about screening programs is speculated to stimulate the market growth.
  • Rising adoption of advanced mammography devices with innovative technologies is estimated to drive the market growth in the coming years.
  • Extensive adoption of artificial intelligence (AI) and machine learning (ML) to improve patient quality of life, which is expected to push the market growth.
  • Ionizing and non-ionizing imaging technologies help in the early detection and diagnosis of breast cancer. Thus, such imaging technologies can boost the market expansion in the projected timeline.
  • High cost of equipment can hamper the market expansion in the coming years.
  • The reduced medical staff availability for cancer treatment due to the COVID-19 outbreak can negatively impacting the breast cancer imaging market.
  • Increasing R&D investment to develop breast cancer imaging systems that provide better sensitivity to detect smaller carcinomas is estimated to create lucrative opportunities for the market players.

Scope of the Report

The report on the global breast cancer imaging market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Breast Cancer Imaging Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types of Imaging Techniques (Mammography, Breast Ultrasound, Breast MRI, Image-guided breast biopsy, and Others), End-users (Hospitals, Diagnostic Centers, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc

 

Breast Cancer Imaging Market Segment Insights

Mammography segment to constitute a large market share

Based on types of imaging techniques, the market is divided into mammography, breast ultrasound, breast MRI, image-guided breast biopsy, and others. The mammography segment is expected to represent a major market share during the forecast period. Rising initiatives taken to increase the awareness about the breast cancer is expected to propel the market growth. Mammography is the standard technique used to screen breast cancer in government and private healthcare hospitals. Government state bodies across the globe are taking initiatives to provide treatment for women between the age 50 and 75, spurring the segment growth.

Hospitals segment to expand a substantial CAGR

In terms of end-users, the market is segmented into hospitals, diagnostic centers, and others. The hospitals segment is anticipated to register a substantial CAGR during the forecast period. Increasing healthcare infrastructure development, higher purchasing power, and availability of well-equipped operating & diagnostic rooms, and better health coverage for healthcare services are expected to proliferate the segment growth.


Breast Cancer Imaging Market by End Users

North America to dominate the market

On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the growing burden of breast cancer coupled with advancement in healthcare infrastructure and rising healthcare expenditure.


Breast Cancer Imaging Market by Regions

Segments

Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of

Types of Imaging Techniques

  • Mammography
  • Breast Ultrasound
  • Breast MRI
  • Image-Guided Breast Biopsy
  • Others

 End-users

  • Hospitals
  • Diagnostic Centers
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • General Medical Merate S.p.A.
  • Aurora Health Care
  • CMR Naviscan Corporation
  • SonoCine, Inc.
  • Dilon Technologies, Inc

Competitive Landscape

Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.

Breast Cancer Imaging Market by Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Breast Cancer Imaging Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Breast Cancer Imaging Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Breast Cancer Imaging Market - Supply Chain
  4.5. Global Breast Cancer Imaging Market Forecast
     4.5.1. Breast Cancer Imaging Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Breast Cancer Imaging Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Breast Cancer Imaging Market Absolute $ Opportunity
5. Global Breast Cancer Imaging Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Breast Cancer Imaging Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Diagnostic Centers
     5.3.3. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Breast Cancer Imaging Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Breast Cancer Imaging Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Breast Cancer Imaging Demand Share Forecast, 2019-2026
7. North America Breast Cancer Imaging Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Breast Cancer Imaging Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Breast Cancer Imaging Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Diagnostic Centers
     7.4.3. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Breast Cancer Imaging Demand Share Forecast, 2019-2026
8. Latin America Breast Cancer Imaging Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Breast Cancer Imaging Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Breast Cancer Imaging Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Diagnostic Centers
     8.4.3. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Breast Cancer Imaging Demand Share Forecast, 2019-2026
9. Europe Breast Cancer Imaging Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Breast Cancer Imaging Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Breast Cancer Imaging Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Diagnostic Centers
     9.4.3. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Breast Cancer Imaging Demand Share Forecast, 2019-2026
10. Asia Pacific Breast Cancer Imaging Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Breast Cancer Imaging Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Breast Cancer Imaging Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Diagnostic Centers
     10.4.3. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Breast Cancer Imaging Demand Share Forecast, 2019-2026
11. Middle East & Africa Breast Cancer Imaging Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Breast Cancer Imaging Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Breast Cancer Imaging Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Diagnostic Centers
     11.4.3. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Breast Cancer Imaging Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Breast Cancer Imaging Market: Market Share Analysis
  12.2. Breast Cancer Imaging Distributors and Customers
  12.3. Breast Cancer Imaging Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. General Medical Merate S.p.A.
     12.4.2. Aurora Health Care
     12.4.3. CMR Naviscan Corporation
     12.4.4. SonoCine, Inc.
     12.4.5. Dilon Technologies, Inc

Segments Covered in the Report
The global breast cancer imaging market has been segmented on the basis of

Types of Imaging Techniques

  • Mammography
  • Breast Ultrasound
  • Breast MRI
  • Image-Guided Breast Biopsy
  • Others

 End-users

  • Hospitals
  • Diagnostic Centers
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • General Medical Merate S.p.A.
  • Aurora Health Care
  • CMR Naviscan Corporation
  • SonoCine, Inc.
  • Dilon Technologies, Inc

Key players competing in the breast cancer imaging market include General Medical Merate S.p.A., Aurora Health Care, CMR Naviscan Corporation, SonoCine, Inc., and Dilon Technologies, Inc.

Breast Cancer Imaging Market by Key Players

Buy Report